Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-7119

ABSTRACT: Transcription profiling of mouse lung upon exposure to BAG6KO or wild type exosomes derived from BV16 cells

PROVIDER: E-MTAB-7119 | ExpressionAtlas | 2019-01-16

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-7119-analysis-methods.tsv	Tabular
	E-MTAB-7119-analytics.tsv	Tabular
	E-MTAB-7119-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-7119-configuration.xml	Xml
	E-MTAB-7119-g2_g1-mvaPlot.png	Other

Items per page:

1 - 5 of 46

Similar Datasets

Lung mesenchymal cells from wild-type mouse lungs

Project description:Lung mesenchymal cells from wild-type mouse lungs

| PRJNA1021966 | ENA

[E-MTAB-368] Transcription profiling by array of mouse embryos at 8 different stages

Project description:Transcription profiling of mouse development The experiment were perfomed as a part of our Vertebrate Evo-Devo project. The aim of the project is to compare transcription profiles of normal (unmanipulated, wild-type, whole embryo) vertebrate embryos.

2011-04-05 | GSE28389 | GEO

Transcription profiling of mouse wild type and DNA repair-deficient primary dermal fibroblasts upon exposure to ultraviolet irradiation

Project description:Transcription profiling of wild type and DNA repair-deficient cells upon exposure to ultraviolet irradiation.

2009-04-01 | E-MEXP-1968 | biostudies-arrayexpress

GNPS Mouse lung lipidomics response to a wild type infectious clone of H7N9 Influenza virus and mutants

Project description:Lipidomics data from mouse lung; Treated with wild-type and mutant H7N9 and mockulum; Time points 1, 2, 4 & 7 days; 5 biological replicates

2022-07-01 | MSV000089784 | GNPS

GNPS - Mouse lung metabolome response to a wild type infectious clone of H7N9 Influenza virus and mutants

Project description:Metabolomics data from mouse lung; Treated with wild-type and mutant H7N9 and mockulum; Time points 1, 2, 4 & 7 days; 5 biological replicates

2015-07-31 | MSV000079206 | GNPS

GNPS - Mouse lung lipidome response to a wild type infectious clone of H7N9 Influenza virus and mutants

Project description:Lipidomics data from mouse lung; Treated with wild-type and mutant H7N9 and mockulum; Time points 1, 2, 4 & 7 days; 5 biological replicates

2016-02-29 | MSV000079542 | GNPS

GNPS - Mouse lung metabolome response to H5N1 (and mutants) and H1N1 Influenza viruses

Project description:Metabolomics data from mouse lung; Treated with wild-type and mutant H5N1, H1N1, and mockulum; Time points 1, 2, 4 & 7 days; 5 biological replicates

| MSV000079327 | GNPS

GNPS - Mouse lung lipidomics response to H5N1 (and mutants) and H1N1 Influenza viruses

Project description:Lipidomics data from mouse lung; Treated with wild-type and mutant H5N1, H1N1, and mockulum; Time points 1, 2, 4 & 7 days; 5 biological replicates

2016-08-05 | MSV000080027 | GNPS

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma [scRNA-seq]

Project description:Lung adenocarcinoma (LUAD), commonly driven by KRAS mutations, is responsible for 7% of all cancer mortality. The first allele-specific KRAS inhibitors were recently approved in LUAD, but clinical benefit is limited by intrinsic and acquired resistance. LUAD predominantly arises from alveolar type 2 (AT2) cells, which function as facultative alveolar stem cells by self-renewing and replacing alveolar type 1 (AT1) cells. Using genetically engineered mouse models, patient-derived xenografts, and patient samples we found inhibition of KRAS promotes transition to a quiescent AT1-like cancer cell state in LUAD tumors. Similarly, suppressing Kras induced AT1 differentiation of wild-type AT2 cells upon lung injury. The AT1-like LUAD cells exhibited high growth and differentiation potential upon treatment cessation, whereas ablation of the AT1-like cells robustly improved treatment response to KRAS inhibitors. Our results uncover an unexpected role for KRAS in promoting intra-tumoral heterogeneity and suggest targeting alveolar differentiation may augment KRAS-targeted therapies in LUAD.

2023-11-01 | GSE246481 | GEO

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma [RNA-seq]

2023-11-01 | GSE246480 | GEO